NEWTOWN, Conn., Aug. 1, 2025 /PRNewswire/ -- The future of the National Mental Health Corps (NMHC)— a leading pipeline into the mental health workforce—is...
WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), today announced that it expects to receive $1 million in grant funding to advance Tevogen.AI, its artificial intelligence–powered drug discovery and development program.